IGFBP7 and acute kidney injury: It has been verified that [TIMP-2] x [IGFBP7] is superior to other biomarkers on detecting AKI in previous cohorts studies [5, 6], which provide early warnings and allow physicians to modify risk, promote intervention and avoid further complications.